Go Africa

Strengthening of Neisseria Gonorrhoeae Antimicrobial Resistance (AMR) Surveillance and Diagnostics in African Partner Countries in the Framework of the WHO Global Action Plan

Short Description

The project Go Africa 2021 aims at promoting WHO’s global action plan on Antimicrobial Resistance (AMR). AMR in Neisseria gonorrhoeae (NG) is a global public health threat. In the WHO African region, 11 million new infections are estimated each year. NG prevention, diagnostics and control remain a great challenge in Africa due to weak and poorly funded STI control programmes, huge data gaps and inadequate access to optimal diagnostics and treatment. We will set up an international cooperation between Nigeria, Rwanda and Germany in order to strengthen NG AMR surveillance in countries with high NG incidence, thereby promoting WHO’s global action plan on AMR.

On basis of a literature analysis and during 2 workshops, experts on STIs, AMR and public health of Nigeria, Rwanda and Germany will assess the current situation of NG AMR in Nigeria and Rwanda in terms of existing diagnostic infrastructure, real-life treatment situation and surveillance and will elucidate important gaps and possible solutions. The findings of the workshops will be used as evidence for a comprehensive follow-up proposal in which specific surveillance and programmatic research activities will be defined. This foundation ensures that gaps, needs and goals are formulated evidence-based and activities for programmatic research and surveillance are feasible.

Project Objectives

  • Setting up a close collaboration between Nigeria, Rwanda and Germany with regard to antimicrobial resistance of Neisseria gonorrhoeae
  • Literature analysis on existing epidemiological data on NG AMR in Nigeria and Rwanda
  • Conducting 2 workshops to elucidate gaps, needs and solutions with regard to diagnostics and treatment of NG AMR in Nigeria and Rwanda and to appropriate surveillance instruments
  • Compiling of a comprehensive follow-up proposal to establish affective surveillance instruments in Nigeria and Rwanda

Last update: June 2021



01.05.2021 - 31.12.2023


ca. 170,000 EUR

Partner Countries

  • Nigeria
  • Rwanda

In Cooperation with

  • Rwanda Biomedical Center (RBC)
  • Nigerian Centre for Disease Control (NCDC)
  • WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections

Implementing Institution

Robert Koch Institute